Reuters logo
BRIEF-Veru Healthcare plans to advance its veru-944 into phase 2 clinical trial
May 24, 2017 / 12:43 PM / 7 months ago

BRIEF-Veru Healthcare plans to advance its veru-944 into phase 2 clinical trial

May 24 (Reuters) - Female Health Co:

* Veru Healthcare - plans to advance its veru-944 into phase 2 clinical trial for treatment of hot flashes in men receiving hormone therapy for prostate cancer

* Veru Healthcare -plan to commence phase 2 trial as soon as possible, and if successful, we expect to begin our phase 3 trial in second half of 2018

* Veru Healthcare - decision to advance the drug followed a pre-investigational new drug application meeting with U.S. FDA Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below